盖博斯组织病理学得分3级分类预测活跃性结肠炎治疗反应
Ichitaro Horiuchi1, Akira Horiuchi2, Kaori Horiuchi2
1Department of Gastroenterology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Journal of clinical medicine
|October 29, 2025
概括
组织病理学可以指导性结肠炎 (UC) 治疗. 患有高中性粒细胞透率 (盖博斯等级≥3.2) 的患者对IL-23抑制剂反应良好,建议针对UC进行个性化治疗.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 组织病理学 组织病理学
背景情况:
- 性结肠炎 (UC) 治疗选择是复杂的.
- 皮质中性友的透表明介素-23 (IL-23) 途径的激活.
- 建议以组织病理学为指导的个性化治疗.
研究的目的:
- 调查上皮质中性粒细胞透是否可以指导UC治疗选择.
- 根据针对性治疗的组织病理学来分层UC患者.
主要方法:
- 对42名活跃UC患者进行前性研究.
- 组织病理学分类 (盖博斯分数) 将患者分层分为≥3.2级和<3.2级.
- 主要结局:4周临床缓解;次要结局:6个月内镜缓解.
主要成果:
- 22名患者的等级≥3.2; 20名患者的等级<3.2.
- 所有22名患者 (等级≥3.2) 使用mirikizumab (IL-23抑制剂) 实现了临床缓解.
- 所有20名患者 (等级<3.2) 通过使用维多利祖马布或乌帕达西提尼布实现了临床缓解.
结论:
- 吉博斯等级≥3.2的UC患者可能受益于IL-23通路抑制剂.
- 基于组织病理学驱动的治疗选择是活跃UC的有希望的策略.
- 这种方法需要进一步验证.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
882
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
882
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
631
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
631
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
532
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
532
Drugs for Treatment of Ulcerative Colitis in IBD
449
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
449
Chronic Bowel Disorders: Introduction
743
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
743
Inflammatory Bowel Disease V: Surgical Management
438
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
438


